The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Revised methods for the Salmonella mutagenicity test
Maron, D. M., & Ames, B. N. (1983) · Mutation Research/Environmental Mutagenesis and Related Subjects · doi:10.1016/0165-1161(83)90010-9 · Cited by 7,386
Ames, B. N., McCann, J., & Yamasaki, E. (1975) · Mutation Research/Environmental Mutagenesis and Related Subjects · doi:10.1016/0165-1161(75)90046-1 · Cited by 7,381
Vermes, I., Haanen, C., Steffens-Nakken, H., & Reutellingsperger, C. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00072-i · Cited by 5,410
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
Adverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050
Polycyclic aromatic hydrocarbons physically intercalate into duplex regions of denatured DNA
Wolfe, A., Shimer, G. H., & Meehan, T. (1987) · Biochemistry · doi:10.1021/bi00394a013 · Cited by 2,049
The comet assay: a comprehensive review
Fairbairn, D. W., Olive, P. L., & O'Neill, K. L. (1995) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(94)00013-3 · Cited by 1,664
Valvular heart disease associated with fenfluramine-phentermine
Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., & Schaff, H. V. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370901 · Cited by 1,632
Predicting in vivo drug interactions from in vitro drug discovery data
Wienkers, L. C., & Heath, T. G. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1851 · Cited by 904
Prediction of Chemical Carcinogenicity in Rodents from in Vitro Genetic Toxicity Assays
Tennant, R. W., Margolin, B. H., Shelby, M. D., Zeiger, E., Haseman, J. K., Spalding, J., Caspary, W., Resnick, M., Stasiewicz, S., Anderson, B., et al. (1987) · Science · doi:10.1126/science.3554512 · Cited by 811
Kirkland, D., Aardema, M., Henderson, L., & Müller, L. (2005) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2005.02.004 · Cited by 754
Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., & Roth, B. L. (2000) · Circulation · doi:10.1161/01.cir.102.23.2836 · Cited by 722
Evans, D. C., Watt, A. P., Nicoll-Griffith, D. A., & Baillie, T. A. (2004) · Chemical Research in Toxicology · doi:10.1021/tx034170b · Cited by 706
Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa.
Portera-Cailliau, C., Sung, C. H., Nathans, J., & Adler, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.974 · Cited by 625
Near Completely Humanized Liver in Mice Shows Human-Type Metabolic Responses to Drugs
Tateno, C., Yoshizane, Y., Saito, N., Kataoka, M., Utoh, R., Yamasaki, C., Tachibana, A., Soeno, Y., Asahina, K., Hino, H., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63352-4 · Cited by 548
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
Blasi, E. R., Rocha, R., Rudolph, A. E., Blomme, E. A. G., Polly, M. L., & McMahon, E. G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00929.x · Cited by 542
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
Zhou, S., Yung Chan, S., Cher Goh, B., Chan, E., Duan, W., Huang, M., & McLeod, H. L. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544030-00005 · Cited by 517
Pharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985).
Prentis, R., Lis, Y., & Walker, Sr. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03318.x · Cited by 471
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme
Masferrer, J. L., Seibert, K., Zweifel, B., & Needleman, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3917 · Cited by 461
Utilization of operational schemes for analog synthesis in drug design
Topliss, J. G. (1972) · Journal of Medicinal Chemistry · doi:10.1021/jm00280a002 · Cited by 457
Possible Role of Valvular Serotonin 5-HT2B Receptors in the Cardiopathy Associated with Fenfluramine
Fitzgerald, L. W., Burn, T. C., Brown, B. S., Patterson, J. P., Corjay, M. H., Valentine, P. A., Sun, J.-H., Link, J. R., Abbaszade, I., Hollis, J. M., et al. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26444-0 · Cited by 440
Mutagen testing using TRP+ reversion in Escherichia coli
Green, M. H. L., & Muriel, W. J. (1976) · Mutation Research/Environmental Mutagenesis and Related Subjects · doi:10.1016/0165-1161(76)90076-5 · Cited by 436
Knockouts model the 100 best-selling drugs—will they model the next 100?
Zambrowicz, B. P., & Sands, A. T. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd987 · Cited by 393
Drug Metabolites in Safety Testing
Baillie, T. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9440 · Cited by 371
Fluorometric and Colorimetric Detection of Caspase Activity Associated with Apoptosis
Gurtu, V., Kain, S. R., & Zhang, G. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2220 · Cited by 354
Adipsin, a Biomarker of Gastrointestinal Toxicity Mediated by a Functional γ-Secretase Inhibitor
Searfoss, G. H., Jordan, W. H., Calligaro, D. O., Galbreath, E. J., Schirtzinger, L. M., Berridge, B. R., Gao, H., Higgins, M. A., May, P. C., & Ryan, T. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307757200 · Cited by 336
Role of Metabolism in Drug-Induced Idiosyncratic Hepatotoxicity
Walgren, J. L., Mitchell, M. D., & Thompson, D. C. (2005) · Critical Reviews in Toxicology · doi:10.1080/10408440590935620 · Cited by 322
Kirkland, D., & Speit, G. (2008) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2008.05.002 · Cited by 318
Hyslop, P. A., & Sklar, L. A. (1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90457-3 · Cited by 315
Calcein accumulation as a fluorometric functional assay of the multidrug transporter
Holló, Z., Homolya, L., Davis, C. W., & Sarkadi, B. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90190-2 · Cited by 315
Animal models of arthritis: relevance to human disease.
Bendele, A., Mccomb, J., Gould, T., Mcabee, T., Sennello, G., Chlipala, E., & Guy, M. (1999) · Toxicologic Pathology · doi:10.1177/019262339902700125 · Cited by 293
Jones, M. B., Krutzsch, H., Shu, H., Zhao, Y., Liotta, L. A., Kohn, E. C., & Petricoin, E. F. (2002) · PROTEOMICS · doi:10.1002/1615-9861(200201)2:1<76::aid-prot76>3.0.co;2-o · Cited by 290
Use and Application of Stem Cells in Toxicology
Davila, J. C. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh100 · Cited by 281
HMG-CoA Reductase Inhibitors and Myotoxicity
Ucar, M., Mjorndal, T., & Dahlqvist, R. (2000) · Drug Safety · doi:10.2165/00002018-200022060-00003 · Cited by 279
Booth, B., & Zemmel, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1384 · Cited by 278
Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular, and Clinical Perspective
Park, B. K., Pirmohamed, M., & Kitteringham, N. R. (1998) · Chemical Research in Toxicology · doi:10.1021/tx980058f · Cited by 267
Drug-Induced Phospholipidosis: Are There Functional Consequences?
Reasor, M. J., & Kacew, S. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020122600903 · Cited by 265
Trends in development and approval times for new therapeutics in the United States
Reichert, J. M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1178 · Cited by 260
The discovery and function of COX-2.
Needleman, P., & Isakson, P. C. (1997) · PubMed · Cited by 256
Identification of putative gene based markers of renal toxicity.
Amin, R. P., Vickers, A. E., Sistare, F., Thompson, K. L., Roman, R. J., Lawton, M., Kramer, J., Hamadeh, H. K., Collins, J., Grissom, S., et al. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6683 · Cited by 256
Self-citationUse of a simplified fluctuation test to detect low levels of mutagens
Green, M. H. L., Muriel, W. J., & Bridges, B. A. (1976) · Mutation Research/Environmental Mutagenesis and Related Subjects · doi:10.1016/0165-1161(76)90077-7 · Cited by 255
Quillardet, P., & Hofnung, M. (1993) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(93)90019-j · Cited by 250
Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?
Cattley, R. C., DeLuca, J., Elcombe, C., Fenner-Crisp, P., Lake, B. G., Marsman, D. S., Pastoor, T. A., Popp, J. A., Robinson, D. E., Schwetz, B., et al. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1997.1163 · Cited by 244
First dose of potential new medicines to humans: how animals help
Greaves, P., Williams, A., & Eve, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1329 · Cited by 243
QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience
De Ponti, F., Poluzzi, E., & Montanaro, N. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050714 · Cited by 240
Sugidachi, A., Asai, F., Ogawa, T., Inoue, T., & Koike, H. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703237 · Cited by 234
Drug-induced phospholipidosis: issues and future directions
Reasor, M. J., Hastings, K. L., & Ulrich, R. G. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.4.567 · Cited by 225
Effects of HMG-CoA Reductase Inhibitors on Skeletal Muscle: Are all Statins the Same?
Evans, M., & Rees, A. (2002) · Drug Safety · doi:10.2165/00002018-200225090-00004 · Cited by 210
Khan, K. N. M., Venturini, C. M., Bunch, R. T., Brassard, J. A., Koki, A. T., Morris, D. L., Trump, B. E., Maziasz, T. J., & Alden, C. L. (1998) · Toxicologic Pathology · doi:10.1177/019262339802600504 · Cited by 201
Self-citationSica, D. A. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-2345-1 · Cited by 192
Lettéron, P., Sutton, A., Mansouri, A., Fromenty, B., & Pessayre, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50309 · Cited by 189
Heijne, W. H., Kienhuis, A. S., van Ommen, B., Stierum, R. H., & Groten, J. P. (2005) · Expert Review of Proteomics · doi:10.1586/14789450.2.5.767 · Cited by 186
Peroxisome proliferation and nongenotoxic carcinogenesis: Commentary on a symposium*1
MOODY, D. (1991) · Fundamental and Applied Toxicology · doi:10.1016/0272-0590(91)90108-g · Cited by 182
Orford, J. L., Fasseas, P., Melby, S., Burger, K., Steinhubl, S. R., Holmes, D. R., & Berger, P. B. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.06.004 · Cited by 182
Toxicogenomics and drug discovery: will new technologies help us produce better drugs?
Ulrich, R., & Friend, S. H. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd710 · Cited by 182
Pharmaceutical Industry Profile
(2005) · Good Design Practices for GMP Pharmaceutical Facilities · doi:10.1201/9780849398537-6 · Cited by 179
Renkiewicz, R., Qiu, L., Lesch, C., Sun, X., Devalaraja, R., Cody, T., Kaldjian, E., Welgus, H., & Baragi, V. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11030 · Cited by 171
Hoffmann, P., & Warner, B. (2006) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2005.07.003 · Cited by 167
Baillie, T. A. (2006) · Chemical Research in Toxicology · doi:10.1021/tx060062o · Cited by 160
Chen, Q., Ngui, J. S., Doss, G. A., Wang, R. W., Cai, X., DiNinno, F. P., Blizzard, T. A., Hammond, M. L., Stearns, R. A., Evans, D. C., et al. (2002) · Chemical Research in Toxicology · doi:10.1021/tx0200109 · Cited by 154
Inflammation and Drug Idiosyncrasy—Is There a Connection?
Roth, R. A., Luyendyk, J. P., Maddox, J. F., & Ganey, P. E. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041624 · Cited by 137
The continuing challenge of predictive factors in rheumatoid arthritis: prediction or association?
van der Heijde, D. M. F. M. (1997) · PubMed · Cited by 135
Prediction of Nephrotoxicant Action and Identification of Candidate Toxicity-Related Biomarkers
Thukral, S. K., Nordone, P. J., Hu, R., Sullivan, L., Galambos, E., Fitzpatrick, V. D., Healy, L. N., Bass, M. B., Cosenza, M. E., & Afshari, C. A. (2005) · Toxicologic Pathology · doi:10.1080/01926230590927230 · Cited by 132
TOXICOGENOMICS IN RISK ASSESSMENT: AN OVERVIEW OF AN ILSI HESI COLLABORATIVE RESEARCH PROGRAM
Pennie, W. D., Pettit, S. D., & Lord, P. G. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6674 · Cited by 128
Waring, J. F., Liguori, M. J., Luyendyk, J. P., Maddox, J. F., Ganey, P. E., Stachlewitz, R. F., North, C. M., Blomme, E. A. G., & Roth, R. A. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.096347 · Cited by 127
The 45-year story of the development of an anti-aldosterone more specific than spironolactone
Ménard, J. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.008 · Cited by 111
The utility of DNA microarrays for characterizing genotoxicity.
Newton, R. K., Aardema, M. J., & Aubrecht, J. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6709 · Cited by 109
In Vivo Detection of Vascular Adhesion Protein-1 in Experimental Inflammation
Jaakkola, K., Nikula, T. K., Holopainen, R., Vähäsilta, T., Matikainen, M., Laukkanen, M., Huupponen, R., Halkola, L., Nieminen, L., Hiltunen, J. O., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64558-0 · Cited by 109
Aryl Acetylenes as Mechanism-Based Inhibitors of Cytochrome P450-Dependent Monooxygenase Enzymes
Foroozesh, M. K., Primrose, G., Guo, Z., Bell, L. C., Alworth, W. L., & Guengerich, F. P. (1997) · Chemical Research in Toxicology · doi:10.1021/tx960064g · Cited by 108
Studies on the mode of action for thyroid gland tumor promotion in rats by phenobarbital
McClain, R. M., Posch, R. C., Bosakowski, T., & Armstrong, J. M. (1988) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(88)90267-0 · Cited by 108
Nile Red Binding to HepG2 Cells: An Improved Assay for In Vitro Studies of Hepatosteatosis
McMillian, M., Grant, E. R., Zhong, Z., Parker, J. B., Li, L., Zivin, R. A., Burczynski, M. E., & Johnson, M. D. (2001) · In Vitro & Molecular Toxicology · doi:10.1089/109793301753407948 · Cited by 107
Asai, F., Jakubowski, J. A., Naganuma, H., Brandt, J. T., Matsushima, N., Hirota, T., Freestone, S., & Winters, K. J. (2006) · Platelets · doi:10.1080/09537100600565551 · Cited by 107
Structural, functional, and molecular characterization of the SHHF model of heart failure
Heyen, J. R. R., Blasi, E., Nikula, K. J., Rocha, R., Daust, H. A., Frierdich, G. E., Vleet, J. F. V., Ciechi, P. D., McMahon, E. G., & Rudolph, A. E. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00305.2002 · Cited by 106
p53 +/- Hemizygous Knockout Mouse: Overview of Available Data
Storer, R. D., French, J. E., Haseman, J., Hajian, G., LeGrand, E. K., Long, G. G., Mixson, L. A., Ochoa, R., Sagartz, J. E., & Soper, K. A. (2001) · Toxicologic Pathology · doi:10.1080/019262301753178465 · Cited by 104
Self-citationWoodyatt, N. J., Lambe, K. G., Myers, K. A., Tugwood, J. D., & Roberts, R. A. (1999) · Carcinogenesis · doi:10.1093/carcin/20.3.369 · Cited by 101
SEROTONIN 5-HT2C RECEPTOR AGONISTS: POTENTIAL FOR THE TREATMENT OF OBESITY
Miller, K. J. (2005) · Molecular Interventions · doi:10.1124/mi.5.5.8 · Cited by 96
Recent update on the PPARα-null mouse
Gonzalez, F. J. (1997) · Biochimie · doi:10.1016/s0300-9084(97)81506-4 · Cited by 95
Investigation of toxic metabolites during drug development
PARK, K., Williams, D. P., Naisbitt, D. J., Kitteringham, N. R., & Pirmohamed, M. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.02.029 · Cited by 94
Thyroid gland neoplasia: non-genotoxic mechanisms
McClain, R. M. (1992) · Toxicology Letters · doi:10.1016/0378-4274(92)90213-4 · Cited by 92
Vignati, L., Turlizzi, E., Monaci, S., Grossi, P., de Kanter, R., & Monshouwer, M. (2005) · Toxicology · doi:10.1016/j.tox.2005.08.003 · Cited by 90
Hu, T., Gibson, D. P., Carr, G. J., Torontali, S. M., Tiesman, J. P., Chaney, J. G., & Aardema, M. J. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2003.11.012 · Cited by 88
Petricoin, E. F., Rajapaske, V., Herman, E. H., Arekani, A. M., Ross, S., Johann, D. J., Knapton, A. D., Zhang, J., Hitt, B. A., Conrads, T. P., et al. (2004) · Toxicologic Pathology · doi:10.1080/01926230490426516 · Cited by 86
Pharmacological interactions of statins
Paoletti, R., Corsini, A., & Bellosta, S. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)00002-8 · Cited by 85
Application of proteomic technologies in the drug development process
Walgren, J. L. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2003.12.047 · Cited by 84
Oxidative Stress Mediated Idiosyncratic Drug Toxicity
Tafazoli, S., Spehar, D., & O'Brien, P. J. (2005) · Drug Metabolism Reviews · doi:10.1081/dmr-55227 · Cited by 83
Blomme, E. A. G., Chinn, K. S., Hardy, M. M., Casler, J. J., Kim, S. H., Opsahl, A., Hall, W. A., Trajković, D., Khan, K. N. M., & Tripp, C. S. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05065.x · Cited by 82
Drug-induced vascular injury—a quest for biomarkers
Expert Working Group on Drug-Induced Vascular Injury (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.08.001 · Cited by 80
Joner, M., Farb, A. A., Cheng, Q., Finn, A. V., Acampado, E., BURKE, A. P., Skorija, K., Creighton, W., Kolodgie, F. D., Gold, H. K., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000251021.28725.e8 · Cited by 74
Macdonald, G. J., Branch, C. L., Hadley, M. S., Johnson, C. N., Nash, D. J., Smith, A. B., Stemp, G., Thewlis, K. M., Vong, A. K. K., Austin, N. E., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030817d · Cited by 74
McKenney, J. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.007 · Cited by 72
Arrhythmogenic mechanisms of non‐sedating antihistamines
Yap, Y. G., & Camm, A. J. (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.0290s3174.x · Cited by 70
Pathogenesis of Cardiovascular Alterations in Dogs Treated with Minoxidil
Mesfin, G. M., Piper, R. C., DuCharme, D. W., Carlson, R. G., Humphrey, S. J., & Zins, G. R. (1989) · Toxicologic Pathology · doi:10.1177/019262338901700113 · Cited by 69
Mechanisms and pathogenesis of thyroid cancer in animals and man
Williams, E. D. (1995) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(95)00138-7 · Cited by 64
Safety Assessment of Biotechnology-Derived Pharmaceuticals: ICH and Beyond
Serabian, M. A., & Pilaro, A. M. (1999) · Toxicologic Pathology · doi:10.1177/019262339902700106 · Cited by 63
Gomez‐Brouchet, A., Pchejetski, D., Brizuela, L., Garcia, V., Altié, M.-F., Maddelein, M., Delisle, M., & Cuvillier, O. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033738 · Cited by 60
The potential use of selective 5-HT2Cagonists in treating obesity
Smith, B. M., Thomsen, W. J., & Grottick, A. J. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.3.257 · Cited by 58
Xpa and Xpa/p53 +/- Knockout Mice: Overview of Available Data
van Kreijl, C. F., McAnulty, P. A., Beems, R. B., Vynckier, A., STEEG, H. V., Fransson-Steen, R., Alden, C. L., Forster, R. P., van der Laan, J. W., & Vandenberghe, J. (2001) · Toxicologic Pathology · doi:10.1080/019262301753178528 · Cited by 58
Shuga, J., Zhang, J., Samson, L. D., Lodish, H. F., & Griffith, L. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701829104 · Cited by 53
ANIMAL MODELS OF CHRONIC BRONCHITIS AND THEIR RELEVANCE TO STUDIES OF PARTICLE-INDUCED DISEASE
Nikula, K. J., & Green, F. H. Y. (2000) · Inhalation Toxicology · doi:10.1080/089583700750019549 · Cited by 51
The Tg.AC (v-Ha-ras) Transgenic Mouse: Nature of the Model
Tennant, R. W., Stasiewicz, S., Eastin, W. C., Mennear, J. H., & Spalding, J. W. (2001) · Toxicologic Pathology · doi:10.1080/019262301753178474 · Cited by 49
Kramer, J. A., Blomme, E. A. G., Bunch, R. T., Davila, J. C., Jackson, C. J., Jones, P. F., Kolaja, K. L., & Curtiss, S. W. (2003) · Toxicologic Pathology · doi:10.1080/01926230309726 · Cited by 49
Self-citationWang, S., Wan, N. C., Harrison, J., Miller, W., Chuckowree, I., Sohal, S., Hancox, T. C., Baker, S. J., Folkes, A. J., Wilson, F. X., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0310129 · Cited by 44
The Pharmacologic Basis of the Cardiovascular Toxicity of Minoxidil in the Dog
Mesfin, G. M., Robinson, F. G., Higgins, M. J., et al. (1995) · Toxicologic Pathology · doi:10.1177/019262339502300406 · Cited by 44
Bolon, B. N. (2004) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2004.pto950402.x · Cited by 43
Murphy, S. M., Palmer, M., Poole, M. F., Padegimas, L., Hunady, K., Danzig, J., Gill, S. S., Gill, R. K., Ting, A. E., Sherf, B. A., et al. (2005) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2005.10.003 · Cited by 39
Hicks, S. M., Vassallo, J. D., Dieter, M. Z., Lewis, C. L., Whiteley, L. O., Fix, A. S., & Lehman‐McKeeman, L. D. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00060-x · Cited by 37
Humanized β-Thalassemia Mouse Model Containing the Common IVSI-110 Splicing Mutation
Vadolas, J., Nefedov, M. D., Wardan, H., Mansooriderakshan, S., Voullaire, L. E., Jamsai, D., Williamson, R., & Ioannou, P. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512931200 · Cited by 35
Broadhead, C. L., Betton, G. R., Combes, R. D., Damment, S. J. P., Everett, D. J., Garner, C., Godsafe, Z., Healing, G., Heywood, R. L., Jennings, M., et al. (2000) · Human & Experimental Toxicology · doi:10.1191/096032700682694242 · Cited by 35
Mesfin, G. M., Higgins, M. J., Robinson, F. G., & Zhong, W.-Z. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0229 · Cited by 35
Immunological approaches to the characterization and diagnosis of mitochondrial disease
Capaldi, R., Murray, J. M., Byrne, L. C., Janes, M. S., & Marusich, M. F. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.07.006 · Cited by 34
Tabacova, S. A. (2005) · Critical Reviews in Toxicology · doi:10.1080/10408440591007160 · Cited by 32
Combinatorial biomarkers: From early toxicology assays to patient population profiling
Koop, R. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03440-9 · Cited by 30
Non‐invasive MRI of mouse models of atherosclerosis
Weinreb, D. B., Aguinaldo, J. G. S., Feig, J. E., Fisher, E. A. A., & Fayad, Z. A. (2007) · NMR in Biomedicine · doi:10.1002/nbm.1148 · Cited by 29
Toxicogenomics: an opportunity to optimise drug development and safety evaluation
Kolaja, K. L., & Kramer, J. A. (2002) · Expert Opinion on Drug Safety · doi:10.1517/14740338.1.3.275 · Cited by 25
Self-citationPetruska, J. M. (1997) · Fundamental and Applied Toxicology · doi:10.1006/faat.1997.2370 · Cited by 23
Gundert‐Remy, U., Dahl, S. G., Boobis, A. R., Kremers, P. G., Kopp‐Schneider, A., Oberemm, A., RENWICK, A. G., & Pelkonen, O. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2004.11.016 · Cited by 21
DNA vaccines: safety aspect assessment and regulation.
Medjitna, T. D. E., Stadler, C., Bruckner, L., Griot, C., & Ottiger, H. (2006) · PubMed · Cited by 20
Nachtigal, P., Pospisilova, N., Pospěchová, K., Jamborova, G., Kopecký, M., Jaynes, R., Briestenský, J., Santar, I., Šmahelová, A., Solichová, D., et al. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.08.041 · Cited by 20
The role of investigative molecular toxicology in early stage drug development
Gross, C. J., & Kramer, J. A. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.2.147 · Cited by 16
Self-citationInhibitor Focusing: Direct Selection of Drug Targets from Proteomes Using Activity-Based Probes
Nomanbhoy, T. K., Rosenblum, J. S., Aban, A., & Burbaum, J. J. (2003) · Assay and Drug Development Technologies · doi:10.1089/154065803321537854 · Cited by 11
Tugwood, J. D., Aldridge, T. C., Lambe, K. G., Macdonald, N., & Woodyatt, N. J. (1998) · Archives of toxicology. Supplement · doi:10.1007/978-3-642-46856-8_33 · Cited by 4
Cited by
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Kim, H. J., Huh, D., Hamilton, G., & Ingber, D. E. (2012) · Lab on a Chip · doi:10.1039/c2lc40074j · Cited by 1,734
Escape from Flatland 2: complexity and promiscuity
Lovering, F. (2013) · MedChemComm · doi:10.1039/c2md20347b · Cited by 1,444
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
Physiochemical drug properties associated with in vivo toxicological outcomes
Hughes, J. D., Blagg, J., Price, D. A., Bailey, S., DeCrescenzo, G. A., Devraj, R. V., Ellsworth, E., Fobian, Y. M., Gibbs, M. E., Gilles, R. W., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.071 · Cited by 946
Metadata
- Authors
- Kramer, J. A., Sagartz, J. E., & Morris, D. L.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-08
- Volume
- 6
- Issue
- 8
- Pages
- 636-649
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2084845010
- Cited by
- 372
- References
- 128
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.